Correlation Between Fresh Tracks and Upstream Bio,

Can any of the company-specific risk be diversified away by investing in both Fresh Tracks and Upstream Bio, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fresh Tracks and Upstream Bio, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Fresh Tracks Therapeutics and Upstream Bio,, you can compare the effects of market volatilities on Fresh Tracks and Upstream Bio, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fresh Tracks with a short position of Upstream Bio,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fresh Tracks and Upstream Bio,.

Diversification Opportunities for Fresh Tracks and Upstream Bio,

0.0

Correlation Coefficient

Fresh Tracks  Upstream Bio,

Pay attention - limited upside

The 3 months correlation between Fresh and Upstream is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Fresh Tracks Therapeutics and Upstream Bio, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Upstream Bio, and Fresh Tracks is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fresh Tracks Therapeutics are associated (or correlated) with Upstream Bio,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Upstream Bio, has no effect on the direction of Fresh Tracks i.e., Fresh Tracks and Upstream Bio, go up and down completely randomly.

Pair Corralation between Fresh Tracks and Upstream Bio,

Given the investment horizon of 90 days Fresh Tracks Therapeutics is expected to under-perform the Upstream Bio,. In addition to that, Fresh Tracks is 1.16 times more volatile than Upstream Bio,. It trades about -0.03 of its total potential returns per unit of risk. Upstream Bio, is currently generating about 0.07 per unit of volatility. If you would invest  1,700  in Upstream Bio, on September 29, 2024 and sell it today you would earn a total of  219.00  from holding Upstream Bio, or generate 12.88% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	40.44%
Values	Daily Returns

Fresh Tracks Therapeutics  vs.  Upstream Bio,

Fresh Tracks Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Fresh Tracks Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Fresh Tracks is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Upstream Bio,

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Upstream Bio, are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Upstream Bio, sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Fresh Tracks and Upstream Bio,

The main advantage of trading using opposite Fresh Tracks and Upstream Bio, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fresh Tracks position performs unexpectedly, Upstream Bio, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Upstream Bio, will offset losses from the drop in Upstream Bio,'s long position.

The idea behind Fresh Tracks Therapeutics and Upstream Bio, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.